Cellebrite DI Ltd.
CLBT
$11.43
-$0.02-0.18%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -67.29% | 10.34% | 181.79% | 124.38% | |
| Total Depreciation and Amortization | 243.94% | 44.41% | 0.62% | -1.83% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 238.46% | 281.06% | -90.40% | -93.43% | |
| Change in Net Operating Assets | -266.11% | 17.63% | 230.69% | 3.33% | |
| Cash from Operations | -46.02% | 31.60% | 124.51% | 107.93% | |
| Capital Expenditure | 14.97% | -24.48% | -74.05% | -56.45% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -124.17% | -641.52% | 241.66% | -55.01% | |
| Cash from Investing | -133.88% | -1,443.11% | 221.98% | -55.04% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -73.90% | -65.23% | 315.94% | -28.59% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -73.90% | -65.23% | 315.94% | -28.59% | |
| Foreign Exchange rate Adjustments | -93.76% | 103.89% | 3,695.92% | 237.00% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -91.48% | -383.68% | 673.46% | -50.83% | |